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ACE POLICY SYMPOSIUM
The Emerging HIV Epidemic on the Mexico-U.S. Border:
An International Case Study Characterizing the Role of Epidemiology
in Surveillance and Response
STEFFANIE A. STRATHDEE, PHD, CARLOS MAGIS-RODRIGUEZ, MD, MPH, PHD,
VICKIE M. MAYS, PHD, MSPH, RICHARD JIMENEZ, DRPH, AND THOMAS L. PATTERSON, PHD
PURPOSE: Human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome surveillance
data are critical for monitoring epidemic trends, but they can mask dynamic subepidemics, especially in
vulnerable populations that underuse HIV testing. In this case study, we describe community-based
epidemiologic data among injection drug users (IDUs) and female sex workers (FSWs) in two northern
Mexico-U.S. border states that identified an emerging HIV epidemic and generated a policy response.
METHODS: We draw from quantitative and qualitative cross-sectional and prospective epidemiologic
studies and behavioral intervention studies among IDUs and FSWs in Tijuana, Baja California, and Ciudad
Juarez, Chihuahua.
RESULTS: The recognition that the HIV epidemic on Mexico’s northern border was already well estab-
lished in subgroups in whom it had been presumed to be insignificant was met with calls for action and
enhanced prevention efforts from researchers, nongovernmental organizations, and policy makers.
CONCLUSIONS: Successful policies and program outcomes included expansion of needle-exchange
programs, a nationwide mobile HIV prevention program targeting marginalized populations, a successful
funding bid from the Global Fund for HIV, TB, andMalaria to scale up targeted HIV-prevention programs,
and the establishment of bi-national training programs on prevention of HIV and substance use.We discuss
how epidemiologic data informed HIV prevention policies and suggest how other countries may learn from
Mexico’s experience.
Ann Epidemiol 2012;22:426–438.  2012 Elsevier Inc. All rights reserved.
KEY WORDS: HIV, AIDS, Surveillance, Policy, Mexico, U.S. border, Epidemiology, Injection drug use,
Sex work.
INTRODUCTION
Surveillance data play a critical role in the monitoring of
epidemiologic trends and programmatic responses to infec-
tious disease threats both nationally and globally. There is
a long history in public health disease control and prevention
in which epidemiologic and surveillance data have informed
policy and interventions to reduce or alter risk even in the
absence of knowing the underlying mechanisms of disease
transmission (1). In 1983, epidemiologic studies before the
isolation of human immunodeficiency virus (HIV) had
already identifiedmany risk factors for which controlmeasure
policies were subsequently developed (1, 2). However,
national and regional HIV/acquired immunodeficiency
syndrome (AIDS) surveillance data can sometimes mask
dynamic subepidemics that vary by country, region, sex, or
HIV transmission group, especially when HIV incidence is
increasing in vulnerable populations that underuse HIV
testing and treatment services. In many countries, HIV/
AIDS surveillance data are limited to programmatic data
from clinics testing antenatal women, those being screened
for sexually transmitted infections (STIs), or routine HIV
testing amongmilitary personnel. The reliance on these types
of sources, rather than HIV testing data drawn from
community-based populations, can lead to erroneous conclu-
sions about country-level HIV epidemic trends and the
presumed impact of prevention interventions andpolicies (3).
Among the country-level HIV prevalence estimates
across the Americas, Mexico’s nationwide prevalence of
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Selected Abbreviations and Acronyms
AIDS Z acquired immunodeficiency syndrome
FSW Z female sex worker
HIV Z human immunodeficiency virus
IDU Z intravenous drug user
NEP Z needle-exchange programs
NGO Z nongovernmental organization
NIDA Z National Institute on Drug Abuse
STI Z sexually transmitted infections
0.3% is among the lowest. By 2007, there were an estimated
200,000 HIV-positive persons living in Mexico, and at the
end of 2008, a total of 124,505 reported AIDS cases, among
whom the vast majority were attributed to homosexual/
bisexual activity. Since the first AIDS case was reported in
Mexico in 1983 until 2007, the male/female AIDS case ratio
decreased from 10:1 to 3:5 (4). Trends in the prevalence of
HIV nationally by gender and risk group were similar to
AIDS incidence data, but among Mexico’s 32 states, Baja
California–abutting the U.S. state of Californiadhas
consistently had the greatest cumulative incidence of
AIDS cases, second only to Mexico’s federal district, and
the corresponding rate in the border state of Chihuahua
has remained greater than the national average (5).
In 2002, del Rio and Sepulveda (6) reviewed and offered
insights into Mexico’s HIV epidemic and the national
response; they concluded that Mexico had thus far averted
a major HIV epidemic, in contrast to some of its neighbors
(e.g., the United States and Honduras) (6). They pointed to
Mexico’s low national HIV prevalence, even among high-
risk populations such as female sex workers (FSWs), among
whom available HIV prevalence estimates were !1%.
They contended that unlike in the United States, the
HIV epidemic in Mexico had remained ‘‘nuclear,’’ primarily
affecting men who have sex with men in urban settings such
as Mexico City, Guadalajara, Monterrey, and Tijuana (7).
The proportion of AIDS cases attributed to the sharing of
injection equipment among injection drug users (IDUs) in
Mexico had consistently been!5% (6), which was attrib-
uted to the relatively few number of IDUs in most cities (6).
The authors further posited that this relative containment
of the HIV epidemic was a consequence of multiple preven-
tion efforts enacted by governmental and nongovernmental
organizations (NGOs). Since this review was published,
epidemiologic data indicate that Mexico’s HIV epidemic
has evolved and that these assumptions require re-
examination.
In this case study, we contrast Mexico’s national and
state-level HIV epidemic profile with data drawn from
cross-sectional and prospective cohort studies conducted
in two northern Mexican cities bordering the United States
(Tijuana Baja California and Ciudad Juarez, Chihuahua).
We then discuss how HIV/AIDS surveillance data initially
perpetuated spurious assumptions about the HIV epidemic
profiles in these states and in Mexico overall, which
hampered timely responses for targeting appropriate preven-
tion and treatment. We show how epidemiologic data used
in conjunction with qualitative data led to the recognition
that the HIV epidemic in the Mexico–U.S. border region
had already become well established in specific subgroups
that had been presumed to be insignificant and isolated,
many of whom were highly mobile.
These data played a significant role in stimulating calls
for action from researchers, NGOs, and state policy makers.
Several successful outcomes included formal endorsement
and expansion of needle-exchange programs as a critical
component to a combined HIV prevention response and
the creation of a nationwide mobile HIV prevention
program targeting marginalized populations. We discuss
this experience in an international context and provide
lessons learned to suggest ways in which other countries
may benefit from how epidemiology played a key role in
formulating policy for HIV prevention efforts. This case
study also highlights the benefits of integrating research
with training in a bi-national context, which is critical for
capacity building and sustained policy responses in
resource-limited settings.
CONTEXTUAL FACTORS: A CONCEPTUAL
FRAMEWORK
As the HIV pandemic has unfolded, investigators, using
epidemiologic and behavioral research, have identified the
role that environments and social structures can play in
the transmission process (8–10). Although behaviors of
individuals are central to HIV transmission, the nonrandom
nature of HIV transmission suggests that disease spread is
influenced not only by virus–host interactions but by differ-
ences in cultural, political, economic, geographic, and social
conditions (8–13).
The underlying framework that best characterizes our
perspective on the intersection between epidemiologic
data and HIV prevention responses in an international
context is that of risk environments (10, 14, 15) and its
corollary of risk clusters (16). Rhodes and colleagues (14,
17) describe the ‘‘HIV risk environment’’ as the spaced
whether social or physicaldin which the interplay of factors
exogenous to the individual increases their likelihood of
engaging in risky behaviors that predispose to HIV infection
or decreases their likelihood of accessing HIV prevention or
treatment (15, 17). These exogenous factors can be catego-
rized in terms of types (i.e., physical, social, economic,
policy) that interact at the micro- and macro-levels of envi-
ronmental influence. There are several important implica-
tions of this perspective.
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First, this heuristic implies that HIV prevention is not
merely a function of an individual’s behavior but also a func-
tion of social, economic, and policy environments that act
as risk regulators to present constraints and/or opportunities
that shape individual behaviors (18). This approach there-
fore shifts the onus of responsibility for behavior change
away from the individual and towards governments and pol-
icymakers, who should be tasked with creating and
sustaining environmental conditions that promote safer
behaviors (11, 17).
Second, the concept that HIV risk stems from a conflu-
ence of environmental factors operating at multiple spheres
of influence requires that epidemiologists go beyond
a narrow characterization of individual behaviors that
confer protection or risk, to measure contextual circum-
stances that can help uncover the interactions, processes,
and pathways that explain disease risk (11). Mixed methods
approaches that integrate classical epidemiologic data
collection with social science methodologies (e.g., ethno-
graphic and qualitative data collection) are especially useful
and can be incorporated into case-control studies, prospec-
tive cohorts, or randomized controlled trials (19).
Finally, the risk environment heuristic is consistent with
the notion that HIV infections do not occur randomly
within a population, and are prone to clustering (16). It is
not just a matter of which environmental factors are
operating, but the fact that some subpopulations are more
likely than others to experience a social structure in which
risk factors intersect and cluster to potentiate HIV spread
within a network (13). Farley’s conceptual model of risk
clustering suggests that it is not each risk factor itself that
creates risk for HIV infection but rather the circumstances
of how they cluster together to create an almost inescapable
vulnerability (16). Below and in Figure 1, we describe factors
at the physical, social, economic, and policy environment
that appear to influence the HIV risk environment and
risk clustering on the Mexico-U.S. border, based on the
cumulative body of research.
Unique Features of the HIV Risk Environment in the
Mexico-U.S. Border Region
The geographic and social landscape helps explain why the
Mexico-U.S. border region is at heightened risk for infec-
tious diseases such as HIV. Like many border regions, it is
characterized by an economically disadvantaged population
and exists as a nexus for drug use, prostitution, and mobility,
as described in the sections to follow.
Place. The 2000-mile border between the United States
and Mexico, which is the most extensive land frontier sepa-
rating a developed and developing country, is a study in
contrasts. The gap in median incomes between inhabitants
of Mexico and the United States is the greatest between any
FIGURE 1. Conceptual framework depicting factors in the HIV risk environment operating in the Mexico–U.S. border region. *Factors
supported by research in Mexico.
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two contiguous countries (20). Of the 12.5 million people
living in the Mexico–U.S. border region, 5.7 million live
in Mexico, of whom, more than one-quarter live below
the poverty index and only 41% of those ages 25 years
and older have completed elementary school education
(20). If this border region were to constitute the 51st U.S.
state, it would rank last in health care access and per-
capita income. It would also rank first in the number of
school children living in poverty and without health care
(21). Among the six Mexican–U.S. border states, Baja
California has among the greatest number of physicians
per capita (125 per 100,000) but the lowest number of
hospitals/clinics (8.4 per 100,000) (20).
The inhabitants of the Mexico–U.S. border region tend
to be young; 28.0% of Mexican border inhabitants are
younger than 13 years of age (20). The large youth popula-
tion in Mexico combined with their HIV-related vulnera-
bilities is one of the concerning factors that should drive
prevention efforts. A significant percentage of Mexican
youth (81%) start drinking by the age of 14 (22, 23) and
come into contact with drugs or psychoactive substances
between the ages of 12 and 29 years of age (22, 24).
Drug Trafficking and Drug Use. After Colombia,
Mexico is the second most important source of heroin
entering the United States (25); 90% of all methamphet-
amine entering the United States is produced in Mexico,
and 70% of all cocaine entering the United States passes
through Mexico (26) en route from South America. As
a consequence, Tijuana and Cd. Juarez are situated onmajor
drug-trafficking corridors (25). Illicit drug usedparticularly
injection drug usedhas increased in Mexico during the past
10 years as local consumption markets emerged along these
trafficking routes. In 1988, the first National Addictions
Survey reported that 0.1% of the Mexican population used
heroin, of whom 17,000 reported use in the previous year.
By the time National Addictions Survey was conducted in
1993, 30,000 Mexicans reported heroin use in the previous
year (27).
The greatest consumption of illegal drugs in Mexico is in
Baja California. The proportion of the general population in
Tijuana who are 12 to 65 years of age and who reported
having ever used an illegal drug was 15%, which is almost
three times the national average (28). In Mexico overall,
men were 13 times more likely than women to have ever
used an illicit drug, but in Tijuana the ratio was 6:1 (28).
Tijuana has one of the fastest-growing IDU populations in
Mexico. By 2002, heroin was the primary reason for seeking
treatment for those attending drug treatment facilities in
Tijuana (29); among those, nearly one-half reported that
their onset of illicit drug use was between 10 and 14 years
of age. Officials estimate there werew6000 IDUs attending
shooting galleries in Tijuana in 2003, but the total number
of IDUs in the city is thought to be closer to 10,000 (30).
Among Mexican cities, Cd. Juarez is ranked second only
to Tijuana in the number of illicit drug users, which is twice
the national average. In 2001, it was estimated that there
were w6000 ‘‘heavy’’ heroin users in Cd. Juarez and as
many as 186 picaderos (i.e., shooting galleries) (31) where
IDUs rent and/or buy used needles. At least 200 picaderos
were known to authorities in Tijuana in 2003 (30).
Shooting galleries are uncommon in Western U.S. cities
but are well known in the eastern U.S. and Puerto Rico,
which experienced dramatic IDU-associated HIV epidemics
linked to needle sharing in these establishments (32).
However, addiction and infectious diseases are not the
only health problem Mexico experiences related to drug
use. Since 2007, more than 20,000 drug-related fatalities
occurred nationwide in Mexico in association with warring
drug-trafficking organizations. Ciudad Juarez and Tijuana
have borne a disproportionate number of these deaths.
Legal and Social Context of Sex Work. Sex work is
quasi-legal in Mexico. Sex with FSWs is encouraged as
a display of virility and ‘‘machismo’’ at all socioeconomic
levels (33). Many Mexican–U.S. border cities have thriving
prostitution districts, or zona rojas (i.e., red light districts),
frequented by thousands of U.S. and foreign tourists each
year. Qualitative research suggests that most sex workers
enter prostitution out of economic necessity, perhaps
because of a failed relationship or poor working conditions
in maquiladoras (i.e., manufacturing plants), and 95% have
children (34). In some cities, such as Tijuana, a registration
permit is required to practice sex work in the zona roja, but
in practice, about one-half of the city’s estimated 9000
FSWs work without permits (35) and less than 5% of
FSWs who inject drugs have permits. In other cities, such
as Ciudad Juarez, the zona rojas exist less formally, and
many sex workers have been recently displaced because of
gentrification.
In Tijuana, FSWs who work in bars, motels, massage
parlors, and street corners are typically highly concentrated
within the zona roja, and the authors of a spatial epidemi-
ology study indicated that relatively few sex work venues ac-
counted for a large proportion of the STI burden (36). In
addition, FSWs working at high-risk venues were more
likely to speak English, to report drug use during sex, and
were less likely to be registered with the health department.
The zona roja in Tijuana also overlaps the Zona Norte,
a border neighborhood known for its high density of IDUs,
which leads to overlapping risks. In a recent study, nearly
one-half of FSWs who injected drugs in Tijuana and Ciudad
Juarez had initiated sex work before they were 18 years of
age, and those that did so were more likely to report that
their initiation into injection drug use had been through
force (37). In our study of 400 male U.S. and Mexican
men who had paid for sex with FSWs in Tijuana, one-half
reported having unprotected sex with FSWs within the
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last 4 months (38), which was associated with drug use
during sex (39).
Migration, Cross-border Mobility, and Deportation.
Vast economic disparities between the United States and
Mexico have fueled a major migration boom, drawing
Mexican migrants to the United States and its border cities
in search of employment. The number of manufacturing
plants in the region exploded after North American Free
Trade Agreement; by 2001, 2700 maquiladoras were opera-
tional predominantly from U.S. businesses. Between 1990
and 2000, the Mexico–U.S. border region experienced
a 21% increase in population size (40), more than double
the U.S. national average (40).
The Mexico–U.S. border region is also characterized by
high levels of cross-border mobility. In 2008 alone, there
were 44 million registered northbound crossings from Tijua-
na to San Diego County (41), making this the busiest land
border crossing in the world. Mobile populations are often
at greater risk of acquiring HIV because of changing social
networks in the context of social isolation, loneliness, and
the lure of anonymity (42). In our study of U.S. male clients
of FSWs who had paid for sex in Tijuana in the last year, we
found that they had crossed the border to pay for sex a mean
number of 26 times (38). Tijuana and Ciudad Juarez are also
primary corridors for migrants and truckers traveling from
Central America and Southern Mexico en route to the
United States. Similar dynamics of truck routes as major
corridors for HIV/STI transmission have been seen in South
Africa (43) and also in the United States, as the result of
drug users from the Northeast traveling to the South via
I-95 (44, 45).
U.S. immigration policies pose a considerable challenge
to HIV prevention efforts in the United States and in
Mexico. In the United States, undocumented persons are
ineligible for health care and unable to access HIV testing
and treatment. Between 1999 and 2007, the U.S. deported
w4.8 million migrants to Mexico; of these, >1.1 million
migrants (w23%) were deported to Tijuana (46, 47).
Many deportees stay in Tijuana to await U.S. re-entry; in
2010, more than one-half of those detained at the U.S.–
Mexico border had been detained previously. Deportees
are typically left at the border with no identification, few
possessions, and no source of income. Many turn to drug
dealing, substance use, or sex work out of desperation (48).
High levels of voluntary and involuntary mobility have
influenced the sociodemographic profile of populations at
high risk for HIV infection, along with their drug use and
HIV risks. Among FSWs and IDUs in Tijuana and Ciudad
Juarez, more than two-thirds are migrants, primarily from
southern Mexican states and Central America (49, 50).
Nearly one-half of migrants voluntarily returning to Mexico
have ever used illicit drugs (51). Among male IDUs in
Tijuana, those who had been deported from the United
States were more likely to have inject drugs daily but were
less likely to receive medical care, to have ever been tested
for HIV, or to have attempted drug treatment (50).
Cross-border HIV transmission is bi-directional. Across
Mexico, 12.7% of Mexico’s accumulated HIV cases re-
ported through 2000 were migrants to the United States
(52). However, the proportion of reported AIDS cases of
Hispanic origin in San Diego County more than doubled
from 19% during 1985–1989 to 44% during 2000–2004
(53). Without proper context, these statistics can spark
a blame game, through which each country feels that its
HIV cases are the fault of the other, which undermines
efforts to improve HIV prevention and treatment on both
sides of the border.
The Role of Religion. Almost 95% of Mexicans are
Roman Catholics (22). The strong influence of the Catholic
Church has thwarted attempts to make condoms widely
accessible (54). In Mexico, some of those most vulnerable
to the risk of HIV infection are those engaging in survival
sex. Advocating for the use of a condom to prevent HIV
transmission may seem reasonable, but this kind of leader-
ship is largely lacking in Mexico. This opposition by the
Church makes it difficult if not impossible in some areas
to freely distribute condoms as a part of HIV prevention.
For example, Church leaders in Tijuana have vehemently
opposed harm-reduction measures (54). In both Tijuana
and Ciudad Juarez, various religious groups frequently oper-
ate drug-treatment programs, some of which are not regu-
lated by the state and have been accused of human rights
violations (55).
Access to Sterile Syringes. TheU.S. Congressional ban
on federal support for needle-exchange programs (NEPs)
and the U.S. lobby to prevent neighboring countries from
supporting harm reduction contributed to Mexico’s slow
adoption of NEPs. Until the mid-2000s, the only active
Mexican NEP was operated by an NGO in Ciudad Juarez,
which began in the late 1980s and was unofficially sanc-
tioned byChihuahua’s Secretary ofHealth. In 2004, Tijuana
opened the second NEP in the country, operated by Preven-
casa A.C. (56, 57) Meanwhile, CENSIDA and the National
drug program (Consejo Nacional contras las Adicciones;
CONADIC) published a position paper supporting harm
reduction, including NEP, in 2003 (57), but its impact was
limited until epidemiologic data spurred health officials to
enact them more broadly (see timeline, Table 1).
EPIDEMIOLOGIC STUDIES OF HIV AND STIS
AMONG IDUs AND FSWs IN TIJUANA AND
CIUDAD JUAREZ
The first sign that drug use was more closely linked to HIV
infection in the Mexico–U.S. border region than early
surveillance data had suggested arose from a study of
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O1000 pregnant women in Tijuana in 2003 (58). The prev-
alence of HIVwas 1% overall and 6% among those who used
drugs; all HIV cases were previously unidentified. Although
Mexico reports low numbers of HIV-infected infants, Baja
California and Chihuahua have had among the greatest
rates of congenital syphilis in Mexico (59), which was an
early warning that untreated syphilis could be serving as
a cofactor of HIV transmission.
From 2004 to 2006, baseline results from a study of 924
FSWs in Tijuana and Cd. Juarez found that HIV prevalence
was 8%; correlates of HIV infection included injection of
cocaine and snorting/smoking methamphetamine (60).
HIV prevalence was 12% among the subsample of FSWs
who inject drugs in these cities, among whom nearly one-
half had at least one active STI (61). HIV incidence among
FSWs randomized to the control group of a subsequent
behavioral intervention was 2 per 100 person-years (62).
In 2004, a qualitative study of IDUs in Tijuana and Ciu-
dad Juarez was conducted through a partnership between
UCSD researchers (authors S.A.S., T.L.P., and C.M.R.),
Mexican NGOs (Programa Companeros and ProComuSI-
DA), and Mexican health officials at the municipal, state,
and federal levels. This study found that in both cities, nee-
dle sharing was normative and that problematic police prac-
tices such as confiscating syringes and arresting the IDUs on
the basis of their disheveled appearance led IDUs to resort to
injecting in shooting galleries (i.e., places in which IDUs
inject drugs in groups with syringes that are rented or
bought) (30, 63). Despite the fact that it was legal to
purchase syringes at pharmacies without a prescription in
Mexico, in-depth interviews found that pharmacists often
refused to sell syringes to IDUs, or charged them exorbitant
prices, taking advantage of their desperate need to assuage
their withdrawal symptoms (30, 64).
Drawing from these observations, the authors of a cross-
sectional study subsequently recruited 207 IDUs in Tijuana
and 197 in Ciudad Juarez through respondent-driven
sampling. In Tijuana, recruitment of street-based IDUs was
facilitated by the use of a modified recreational vehicle
donated by theUCSD research team to one of the NGOpart-
ners. This prevemovihl (i.e., HIV prevention mobile) success-
fully accessed high-risk participants in the callejones (i.e.,
alleys), and in the rural colonias (i.e., neighborhoods). In
both cities, HIV prevalence was low at 3% (65), but HCV
prevalence was 95% (66). These data suggested that sharing
of needles and other injection equipment in these cities could
support an HIV epidemic because parenteral transmission of
HCV and HIV is highly efficient. In particular, police confis-
cation of used and sterile syringes was associated with three-
fold higher odds of receptiveneedle sharing in both cities (67).
A subsequent prospective study of 1056 Tijuana IDUs
funded by the National Institute on Drug Abuse found
that HIV prevalence among male IDUs remained low at
4% from 2006 to 2008 but had increased to 10% among
female IDUs (68). Social and structural factors were more
closely associated with HIV infection than individual-
level behaviors. Specifically, among male IDUs, factors
independently associated with HIV infection included in-
jecting in groups, deportation from the United States, and
being arrested for carrying used syringes, whereas among
TABLE 1. Timeline depicting HIV epidemiology surveillance and research in Mexico and the Response in the Mexico–U.S.
border region
1983 First AIDS case reported in Mexico
1986 First heterosexual case of HIV among an IDU reported to the Mexican Federal health authorities
1988 Needle exchange began informally in Ciudad Juarez by an NGO (Programa Compa~neros)
1990 Federal epidemiological HIV Surveillance in IDUs began in Baja California
2000 CONASIDA and the NGO Programa Compa~neros published the first harm reduction manual
2003 The Mexican federal government published a position paper with the first open endorsement of the harm reduction programs
2004 The Mexican federal government develops workshops in Mexican border states for the implementation of harm reduction activities
2005 Baja California, Chihuahua, and Sonora formally begin needle-exchange programs
2006 Conasida began to distribute syringes to state-level AIDS programs
2007 Conasida commissioned a fleet of condonetas for all Mexican states, inspired by Tijuana’s Prevemovihl and
the NGO Colectivo Sol’s Condomovil in Mexico City
2007 Needle-exchange programs now formally operating in seven Mexican states (Baja California, Chihuahua, Coahuila,
Nuevo Leon, Oaxaca, Sonora, Zacatecas)
2007–2008 Mexican federal government establishes the first free-standing HIV/AIDS clinics in Tijuana and Ciudad Juarez (CAPACITS clinics)
2008 During the International AIDS Conference in Mexico City CONASIDA and Baja California authorities presented the first harm
reduction video with BC minister of health promoting harm reduction
2009 Possession of small amounts of illicit drugs were decriminalized across Mexico
Mexico was awarded $76M in Global Fund resources in response to the HIV epidemiological data presented
2010 Mexican federal authorities signed the Vienna Declaration (www.viennadeclaration.com)
2010 Baja California Secretary of Health and federal Mexican health authorities publish Lancet commentary embracing harm reduction
and decriminalization
AIDS Z acquired immunodeficiency syndrome; HIV Z human immunodeficiency virus; IDU Z injection drug user; NGO Z nongovernmental organization.
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female IDUs, HIV risk was independently associated with
living in Tijuana for longer durations (68). A spatial analysis
of HIV infections also found that these HIV infections were
initially clustered in the ZonaNorte, but incident HIV infec-
tions became dispersed after 2006, which coincided approx-
imately with the escalation of violence and federal army
presence that displaced many IDUs (69). A later study
among FSWs who injected drugs in Tijuana and Cd. Juarez
found that police confiscation of syringes and sharing nee-
dles with clients were both independently associated with
HIV infection (70).
In addition to identifying environmental factors that
exacerbated HIV risk behaviors, we found low coverage of
HIV and STI testing and treatment programs, which ap-
peared to be due in part to their centralized locations outside
of the highest risk neighborhoods. In Tijuana and Ciudad
Juarez, data from 2004 to 2006 suggested that only 49% of
FSWs and 30% to 38% of IDUs had ever had an HIV test
(71). Syphilis was consistently identified as being indepen-
dently associated with HIV infection among IDUs, FSWs,
and their clients (38, 60, 72). This was not surprising
because approximately one-half of these syphilis infections
had titers O1:8, which is consistent with active infections
that facilitate HIV transmission. Collectively, these studies
suggest that factors operating at various levels in the HIV
risk environment were central to shaping individual HIV
risk behaviors in both cities.
Data accumulating from these epidemiologic studies
were among the first estimates of HIV prevalence among
FSWs and IDUs in the Mexico–U.S. border region and
began to challenge assumptions that had been made about
the context of the Mexican HIV epidemic. First, these
data underscored the extent to which Mexico’s HIV
epidemic was not a single epidemic but had become regional
subepidemics. Second, HIV prevalence among FSWs and
female IDUs in Tijuana and Ciudad Juarez was much greater
than expected, on the basis of HIV surveillance data. Third,
it was now indisputable that there was considerable overlap
between communities engaged in sex work and drug use.
Finally, the importance of the HIV risk environment in
shaping individual-level HIV risk behaviors could not be
ignored, indicating that the responsibility for change should
rest more on the shoulders of policy makers and program
planners, rather than individuals themselves or the small
under-resourced NGOs that served them.
LEVERAGING DATA TO INFLUENCING POLICY:
THE ROLE OF EPIDEMIOLOGY
How could these epidemiologic data be leveraged to generate
thoughtful policy changes without the United States or
Mexico blaming each other for its HIV epidemic? Members
of our binational team, which included federal and state
health officials, NGO leaders, and researchers, spent long
hours contemplating this problem and embarked on a strategy
to elicit a binational response. On the basis of available HIV
prevalence and census data, we conducted a modeling exer-
cise to estimate the number ofHIV-infected persons inTijua-
nabyusing a low-risk andahigh-risk scenario. In thehigh-risk
scenario, models were generated on the basis of the upper end
of the 95%confidence intervals for eachHIVprevalence esti-
mate, which suggested that one in 125 persons aged 15 to 49
in Tijuana was infected with HIV in 2005 (73). These data
indicated that that the city’s HIV epidemic had moved
from low-level to concentrated, according to UNAIDS cate-
gorizations. Epidemiologic data were used to demonstrate the
extent to which mobility was bi-directional among high-risk
populations at the Mexico–U.S. border, which emphasized
the potential for cross-border transmission of HIV and STIs
from north to south or vice versa.
Coinciding with its publication in 2006, the findings
from this paper were prepared in a press release in Spanish
and English; shared with municipal, state, and federal
health officials in Mexico before the press embargo was
lifted; and released simultaneously to media in both coun-
tries. The findings received widespread coverage in both
countries, and the research team was subsequently invited
to present policy recommendations to theGovernor of Baja
California and the Mayor of San Diego in a joint meeting.
Meanwhile, the Secretary of Health of Baja California,
who had formerly served as the Health Commissioner in
Tijuana, stated publicly that he endorsed NEPs as a critical
component of a comprehensive strategy to prevent HIV
infection. By 2008, dedicated HIV clinics (CAPACITS)
were established in Tijuana and Ciudad Juarez. However,
in Tijuana, local pressures from some religious and political
figures forced the clinic to be located away from colonias
where HIVwas most concentrated, which remains a barrier
to HIV care for vulnerable populations without means of
transportation.
In 2007, following the example of using mobile vans for
HIV prevention service delivery that had been employed
both in Mexico City and by our NGO partner’s Prevemovihl
in Tijuana, federal and state health officials in Mexico
commissioned a fleet of customized mobile vans that would
later be delivered to every Mexican state. Equipped with
a loudspeaker on the roof, a TV screen in the rear, adequate
space for outreach workers to provide condoms and
exchange syringes, and painted neon green with caricatures
of dancing condoms, the condoneta was born. In conjunc-
tion, the national guidelines supporting harm reduction
that had been published by CENSIDA without fanfare in
2005 now had ample epidemiologic data to justify the imple-
mentation of NEPs across Mexico. By 2007, there were
small-scale NEPs supported byMexico’s federal government
operating in seven statesdBaja California, Chihuahua,
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Coahuila, Nuevo Leon, Oaxaca, Sonora, and Zacatecasd
and by 2010, nine Mexican states had NEPs.
The team also learned that the press could wield
a double-edged sword. In 2008, a study of the male clients
of FSWs in Tijuana showed that HIV prevalence was 5%
and was equivalent among the clients who lived in the
U.S. versus Mexico (38). More than two-thirds of FSWs
in Tijuana and Ciudad Juarez reported being patronized by
clients from the United States; these FSWs reported
a greater tendency to inject drugs, have syphilis, and engage
in unprotected sex for higher pay (74). However, the highly
politicized nature of these data proved difficult to manage;
the headline from the San Diego Tribune read: ‘‘Sex with
Americans Risky for Mexican Hookers.’’
Amore successful approachwasmet byworking withU.S.
health officials at theNational Institute of Health to identify
research questions that were of public health significance to
both Mexico and the United States, which subsequently
led to six successful peer-reviewed R01 grant applications
with Mexican Co-PIs. In addition to funding received by
the National Institute on Drug Abuse (NIDA) to study risk
factors for HIV infection among IDUs at the individual,
TABLE 2. Environmental HIV risk factors operating in the Mexico–U.S. border region: Implemented interventions and
recommendations
HIV risk environment
concept (8, 11)*
Environmental
HIV risk factors
identified Recommended intervention Interventions implemented
Physical
Macro physical Migration (68) Dedicated services for migrants –
Macro physical Deportation (48, 50) Change in immigration policies and practices –
Macro physical Sex trafficking (37) –
Macro physical Drug trafficking (25, 26) Monitoring of trends in drug
production, trafficking and use
Decriminalization of drug possession (75)
NIDA-funded study to examine the intended
and unintended consequences of drug policy
reform on drug users’ behaviors and HIV
risks in Tijuana
Micro physical Sex work venue (36, 84) Venue-based interventions engaging bar
owners, managers and jaladores (touts) (36)
Social
Micro social Policing practices
(63, 68, 70)
Educate police on harm reduction,
HIV prevention and occupational
risks of needle-stick injuries
HIV-prevention education curriculum
development for police cadets
Macro social Religion (54, 55, 85) Education and outreach of clergy –
Micro social Risky client
behavior (38, 39)
Develop interventions that reduce clients’
HIV risk behaviors
NIDA-funded study to evaluate behavioral
Intervention for clients of FSWs
Economic
Macro economic Limited HIV prevention
resources (5)
Advocate for targeted funds for HIV
prevention with local, state and federal
policymakers in Mexico and the U.S.
- Global fund for HIV, TB, and Malaria awards
Mexico $76 million USD
Micro political High cost of FSW
registration (35)
Remove financial barriers to registration
Evaluate policy of requiring FSWs to
register to legally engage in sex work (86)
–
Micro economic Pharmacies overcharging
for syringes or refusing
to sell to IDUs (30, 64)
Develop education and interventions
for pharmacists
–
Policy
Micro policy Limited needle
exchange (5, 54)
Federal and state endorsement and expand NEPs
Micro policy Little condom access Expand access to male and female condoms Implementation of the condoneta, a mobile
HIV-prevention unit, in all Mexican states
Macro policy Low access to drug abuse
treatment (55)
Provide free drug treatment on demand
Expand availability of methadone and
buprenorphine maintenance
Federal and state commitments in Mexico to
expand drug abuse treatment
Macro policy STI underdiagnosis
(38, 60, 68, 70)
Integrate HIV, STI diagnosis and
treatment services
–
Macro policy Limited access to HIV
testing/treatment (5, 58)
- Implementation of CAPISITS Clinics in
Tijuana, Juarez and other Mexican cities
FSWZ female sex worker; HIVZ human immunodeficiency virus; IDUZ injection drug user; NEPZ needle-exchange program; NIDAZ National Institute on Drug Abuse;
STI Z sexually transmitted infection.
*Also see Figure 1.
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social and environmental level, bothNIDAand theNational
Institute of Mental Health funded behavioral intervention
studies aimed at increasing condom use and reducing drug-
related risk behaviors among FSWs and their clients. One
such study demonstrated that a brief intervention incorpo-
rating motivational interviewing and role play surrounding
condomuse negotiationwas associated with a 40% reduction
in HIV/STI incidence among FSWs in Tijuana and Ciudad
Juarez (62). A subsequent project was recently funded by
NIMH with support from the Mexican federal government
to study the organizational factors that promote or impede
the scale-up of this intervention in 12 Mexican cities.
In 2010, NIDA funds were awarded to study the impact of
drug policy reform on drug use behaviors in Tijuana,
following Mexico’s enactment of an unprecedented law
that deregulates possession of small specified amounts of
cocaine, heroin, methamphetamine, and marijuana for
personal use (75). The law specifies that police who appre-
hend individuals who possess subthreshold amounts of these
drugs will not pursue penal action until a third apprehension,
when such individuals will be required to enter drug treat-
ment or jail. This law is intended to redirect law enforce-
ment to drug dealers and traffickers while embracing more
of a harm-reduction approach with the scale-up of NEPs
andmethadone-maintenance treatment programs.Whether
these reforms will have an impact on risk behaviors andHIV
incidence is an open question, but in a high-profile Lancet
commentary, national and state-level policymakers publicly
pledged to ensure that their future health and drug policy
decisions are evidence-based and grounded in a human
rights approach (76).
Mexico’s evolving HIV epidemic also garnered an inter-
national response. In 2009, Mexico was successful in its bid
to secure funds from the Global Fund for HIV, TB and
Malaria for the first time. HIV prevalence and incidence
data from the epidemiologic studies conducted on Mexico’s
northern border were instrumental in demonstrating that
the prevalence of HIV had surpassed 5% in more than one
risk group, which was a requirement for Global Fund eligi-
bility. Accordingly, $76M USD was awarded to scale-up
HIV-prevention programs, which includes support for
IDUs in Tijuana and Ciudad Juarez, as well as two cities
where HIV prevalence among IDUs had recently begun to
increase (i.e., Hermosillo and Guadalajara).
Central to the success of these studies is a commitment
to recognizing bi-national partnerships. Study findings
were published following guidelines for publication that
were generated by the team that were included both
U.S. and Mexican partners. NIDA, the Fogarty Interna-
tional Center, Hispanic Serving Health Professions
Schools, and USAID also provided funding to support
training programs to develop research skills and program-
matic capacity-building for both U.S. and Mexican
students and fellows. The majority of the team’s publica-
tions to date have been led by students and fellows,
many of whom are Mexican or Mexican-American.
LESSONS LEARNED
Box 1 (77–79) contrasts our experience in Mexico to an
international case example that has been reported upon
extensively in the HIV prevention literature: The 100%
Condom Campaign in Bangkok, Thailand. In the Thai
example, epidemiologic data were used to generate political
will for a structural HIV prevention intervention enforcing
brothels to comply to consistent condom use or suffer
closure. This was shown to be a highly effective policy for
controlling HIV transmission in brothel-based FSWs.
Box 1. Example of the Thai government’s effective HIV prevention policies and strategies and their impact, 1991–1993.
Policy/strategy Impact
Early recognition of HIV as a national health problem by both the Public
Health Community and Government
Early coordinated collaboration and call to action by two influential public
sector partners focusing on the urgency of the problem (77)
Careful analysis of the epidemiological data and trends, especially among
subpopulations
Early identification of and focus on the more urgent impact and problem of
HIV among sex workers and their clients (78)
Focus on HIV as a Public Health/Medical issue Key partners were able to sidestep issues of morality and religion and focus
on ‘‘high risk behaviors’’ instead of ‘‘high risk groups’’ to prevent HIV
infections (77)
Deliberate and focused plan to recruit key community stakeholders, using
evidence-based data and information on the current and future impact
of HIV on the country
Development of the 100% Condom Use plan in brothels (77, 79)
Early buy-in of the HIV-prevention plan and key interventions among
sex workers and their clients by key public and private stake holders and
partners (77, 79)
Ongoing epidemiological surveillance and evidence based risk reduction
interventions among sex workers and their clients.
Initiated the 100% condom use program in brothels (77, 79)
Increase in the use of condoms by sex workers from 14% in 1989 to 90%
by 1992 (79)
An estimated 200,000 new HIV infections averted between 1993 and
2000 (79)
HIV Z human immunodeficiency virus.
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Reliance on HIV/AIDS Surveillance Data Can Mask
Emerging Regional Trends
Our case study illustrates how Mexico’s early reliance on
national and state-level HIV/AIDS surveillance data
masked an emerging HIV subepidemic on the Mexico–
U.S. border. HIV/AIDS surveillance data from India have
also generated misleading results when inappropriately
extrapolated to the regional level, which led the estimated
number of HIV-infected persons in India to be revised
significantly downward (80). In a review of the quality of
HIV/AIDS surveillance data from 127 low- and middle-
income countries (81), a fully functioning surveillance
system was operating in only 40 countries. The authors rec-
ommended that countries with low-level and concentrated
epidemics should focus on collecting serologic and behav-
ioral data from all high risk populations, which would
provide an early warning signal if HIV prevalence and inci-
dence begins to escalate.
Simple Epidemiologic Data Can Generate Powerful
Responses
Often, epidemiologic researchers rely on large-scale
studies such as longitudinal cohort studies which require
significant time and resource investments to determine
solutions. As demonstrated in this case study, descriptive
data, such as estimates of HIV prevalence, incidence,
and associated risk behaviors can sometimes be sufficient
for stimulating an effective policy response. By showing
that HIV prevalence among some subpopulations in the
Mexico–U.S. border region had surpassed the critical
threshold of 5%, we demonstrated that the HIV epidemic
in this region had shifted from ‘‘low level’’ to ‘‘concen-
trated,’’ making Mexico eligible to receive a large contract
from the Global Fund. Coupled with qualitative data to
provide context, simple epidemiologic data collected
from multiple subgroups was also used to generate an
epidemic profile that informed policy makers and program
planners. This implies the need for community-based part-
nerships that facilitate the development of trust and
sharing of information especially when working with
marginalized populations that typically fall outside the
health care system, and across borders.
The Importance of Risk Environment
Traditionally, epidemiologists are concerned with how indi-
viduals behave and focus interventions at the individual
level. In this case study, environmental factors appeared to
be the most important drivers of individual level risk behav-
iors (68, 70), which is consistent with the HIV risk environ-
ment heuristic (8, 11, 17) and incident HIV cases appeared
to cluster (69), which supports Farley’s conceptual frame-
work (16). Moreover, systems and structural factors were
found to inhibit some subpopulations from accessing preven-
tion programs. As shown in Table 2 (5, 8, 11, 25, 26, 30, 35–
39, 48, 50, 54, 55, 58, 60, 63, 64, 68, 70, 75, 82–85) factors
operating in the physical environment (voluntary and invol-
untary migration), social environment (police and pharma-
cists’ practices that limited access to sterile syringes),
economic environment (poverty, coupled with economic
disparities between the United States and Mexico), and
policy environment (low coverage of HIV and STI testing
and treatment) were important underlying factors driving
HIV transmission, consistent with Rhodes’ heuristic of the
HIV risk environment (14, 17). These findings exemplify
how epidemiologic data were used to shift the responsibility
for interventions towards governments and policy makers
and away from individuals. The research studies presented
in this case study were also informed by theory, which aided
in their application to theory-based interventions. Embed-
ding qualitative research in epidemiologic study designs
was also shown to provide invaluable context and insights
into potential mechanisms of risk and protection.
Mobilizing Key Stakeholders Is Critical for Generating
Timely Policy Responses
This case study illustrates how involvement of policymakers
and partners at all levels from inception is critical for devel-
oping trust, which in turn facilitates an appropriate and
timely policy response. In this context, the team sought
to include both Mexican and U.S. researchers and local
NGOs. We engaged Mexican health officials at the munic-
ipal, state, and federal levels who not only were passive
actors in terms of receiving information but at times played
an active role in disseminating study results and interpret-
ing it for the public. For example, Baja California’s Secre-
tary of Health presented results from our study at the
International AIDS Conference in Mexico City in 2008
(86) and was lead author on a commentary in Lancet that
outlined his strategy for preventing HIV and other drug-
related harms (76), setting an example for other Mexican
states. The case study also showed the benefits of a well-
executed communication plan, by jointly issuing press
releases in the US and Mexico in English and Spanish, to
ensure that communities on both side of the border had
equal access to study results which were used to justify the
development of HIV prevention policies.
CONCLUSIONS
This case study illustrates how epidemiologic data were used
to develop HIV-prevention policies directed at theMexico–
U.S. border region. The body of research presented identi-
fied several avenues for intervention that address structural
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factors that potentiate HIV risks, some of which have been
met with action, whereas others have yet to be addressed
(Table 2). For example, police continue to confiscate
syringes from drug injectors in both Tijuana and Ciudad
Juarez, which undermines harm reduction initiatives such
as NEPs. Although curricula have been developed to sensi-
tize police to harm reduction, it has yet to be incorporated
widely into police trainings across Mexico. Elsewhere in
the United States and in South Asia, success has been met
with police trainings that integrate HIV prevention with
occupational safety (i.e., prevention of needle-stick injuries)
to help align law enforcement with public health goals
(87, 88).
Religious opposition to the promotion of condoms and
sterile syringes in Mexico is another persistent barrier. In
South Africa, advocating for the use of a condom not for
contraceptive purposes, but to prevent the transmission
of HIV has been endorsed by an Archbishop (89). In
a 2010 interview (90), Pope Benedict openly stated
that condom use for HIV prevention may be ‘‘justifiable
in certain situations.’’ Although there has been much
debate by religious leaders regarding what the Pope actu-
ally meant, this was the first time the qualified endorse-
ment of condom use for HIV prevention has come
directly from a Pope, marking an apparent, albeit subtle,
policy shift in the Vatican’s thinking. This may prove
useful for Catholic prelates and pastors in Mexico and
other countries for supporting local efforts in the use of
condoms to prevent HIV infections. Further develop-
ment of HIV prevention policies in the Mexico–U.S.
border region will therefore need to engage leaders
outside the health sector.
Increased awareness of the value and benefits of consid-
ering an ecological approach to assessing ‘‘environments of
risk’’ for HIV infection, not just individual behaviors, and
the subsequent training of epidemiologists, public health
scientists and other professional and lay workers on the
ecological model and approach should lead to more efficient
and targeted HIV prevention interventions throughout the
world. Ongoing critical examination of effective and inno-
vative evidence-based approaches to HIV prevention and
the sharing of successful policies and strategies with those
on the frontlines should be a high priority in the struggle
against the HIV pandemic.
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